Dale Han, MD, FACS

Assistant Professor of Surgery (Oncology)

Research Organizations

Surgery: Surgical Oncology

Yale Cancer Center: Developmental Therapeutics

Selected Publications

  • The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.

    Bello DM, Han G, Jackson L, Bulloch K, Ariyan S, Narayan D, Rothberg BG, Han D. The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma. Annals Of Surgical Oncology 2016, 23:938-945.

  • Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsy.

    Rubinstein JC, Han G, Jackson L, Bulloch K, Ariyan S, Narayan D, Rothberg BG, Han D. Regression in thin melanoma is associated with nodal recurrence after a negative sentinel node biopsy. Cancer Medicine 2016, 5:2832-2840.

  • The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas.

    Stahl JM, Corso CD, Park HS, An Y, Rutter CE, Han D, Roberts KB. The effect of microscopic margin status on survival in adult retroperitoneal soft tissue sarcomas. European Journal Of Surgical Oncology : The Journal Of The European Society Of Surgical Oncology And The British Association Of Surgical Oncology 2017, 43:168-174.

  • Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

    Han D, Thomas DC, Zager JS, Pockaj B, White RL, Leong SP. Clinical utilities and biological characteristics of melanoma sentinel lymph nodes. World Journal Of Clinical Oncology 2016, 7:174-88.

  • Han D, Iyer JG. Prognostic factors and immunobiologic insights in Merkel cell carcinoma. Cancer 2015; doi: 10.1002/cncr.29453. Epub ahead of print.
  • Han D, Han G, Zhao X, Rao NG, Messina JL, Marzban, SS, Sarnaik AA, Cruse CW, Sondak VK, Zager JS. Clinicopathologic predictors of survival in patients with desmoplastic melanoma. PLOS One 2015;10(3):e0119716. doi: 10.1371/journal.pone.0119716. eCollection 2015.
  • Han D, Smalley KSM. Targeting the cell cycle and p53 in combination with BRAF-directed therapy. In: Sullivan RJ, editor. BRAF targets in melanoma - biological mechanisms, resistance, and drug discovery. New York: Springer, 2015.
  • Han, D. Undifferentiated Pleomorphic Sarcoma of the Chest Wall. Case Presentations for Conferences, Thoracic Surgery Curriculum. Joint Council for Thoracic Surgery Education. 2014.
  • Strom T, Caudell JJ, Han D, Zager JS, Yu D, Cruse CW, Marzban SS, Messina JL, Trotti AM, Sondak VK, Rao NG. Radiotherapy influences local control in patients with desmoplastic melanoma. Cancer 2014;120(9):1369-78. doi: 10.1002/cncr.28412. Epub 2013 Oct
  • Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.

    Han D, Zager JS, Shyr Y, Chen H, Berry LD, Iyengar S, Djulbegovic M, Weber JL, Marzban SS, Sondak VK, Messina JL, Vetto JT, White RL, Pockaj B, Mozzillo N, Charney KJ, Avisar E, Krouse R, Kashani-Sabet M, Leong SP. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2013, 31:4387-93.

  • Han D, Turner LM, Reed DR, Messina JL, Sondak VK. Prognostic significance of lymph node metastasis in pediatric melanoma and atypical melanocytic proliferations. Expert Review of Dermatology 2013;8(2):103–106.
  • Han D, Zager JS, Yu D, Zhao X, Walls B, Marzban SS, Rao NG, Sondak VK, Messina JL. Desmoplastic melanoma: Is there a role for sentinel lymph node biopsy? Annals of Surgical Oncology 2013;20(7):2345-2351.
  • Han D, Zager JS, Han G, Marzban SS, Puleo CA, Sarnaik AA, Reed D, Messina JL, Sondak VK. The unique clinical characteristics of melanoma diagnosed in children. Annals of Surgical Oncology 2012;19(12):3888-3895.
  • Han D, Yu D, Zhao X, Marzban SS, Messina JL, Gonzalez RJ, Cruse CW, Sarnaik AA, Puleo C, Sondak VK, Zager JS. Sentinel node biopsy is indicated for thin melanomas >=0.76 mm. Annals of Surgical Oncology 2012;19(11):3335-3342.
  • Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma.

    Deneve JL, Choi J, Gonzalez RJ, Conley AP, Stewart S, Han D, Werner P, Chaudhry TA, Zager JS. Chemosaturation with percutaneous hepatic perfusion for unresectable isolated hepatic metastases from sarcoma. Cardiovascular And Interventional Radiology 2012, 35:1480-7.

  • Han D, Deneve J, Gonzalez RJ. Recurrence risk after resection of gastrointestinal stromal tumors (GIST): Size is not all that matters...the consequences of tumor rupture. The American Surgeon 2012;78(1):74-9.
  • Han D, Beasley GM, Tyler DS, Zager JS. Minimally invasive intra-arterial regional therapy for metastatic melanoma: Isolated limb infusion and percutaneous hepatic perfusion. Expert Opinion on Drug Metabolism and Toxicology 2011;7(11):1383-94.
  • Sondak VK, Han D, Deneve J, Kudchadkar R. Current and planned multicenter trials for patients with primary or metastatic melanoma. Journal of Surgical Oncology 2011;104:430-437.

Edit this profile

Contact Info

Dale Han, MD, FACS
Patient Care Location
Smilow Cancer Hospital at Yale New Haven
35 Park Street

New Haven, CT 06511
View on map...
Mailing Address
Surgical Oncology330 Cedar Street, FMB 130
PO Box 208062

New Haven, CT 06520-8062

Curriculum Vitae